Hypertension, risk factors and coronary artery stenosis: A case-control study

Zahra Sedaghat1, Mohammadjavad Zibaeenejad1, Mohammad Fararouei1

  • 1a HIV/AIDS Research center , HIV/AIDS Research center, Shiraz University of Medical Sciences , Shiraz , Iran (the Islamic Republic of).

Insights

Hypertension is linked to coronary artery stenosis (CAS), but BMI and age are key predictors in individuals without CAS. Coronary artery stenosis significantly alters the relationship between these factors and hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Investigation

Background:

  • Hypertension is a major risk factor for cardiovascular diseases (CVDs).
  • The precise nature of the association between hypertension and CVD risk factors requires further elucidation.
  • Coronary artery stenosis (CAS) is a critical manifestation of CVD.

Purpose of the Study:

  • To investigate the associations of serologic, anthropometric, and coronary artery stenosis (CAS) with blood pressure.
  • To determine the predictive value of Body Mass Index (BMI), age, and abdominal obesity in relation to hypertension.
  • To explore how CAS influences the relationship between these factors and hypertension.

Main Methods:

  • A case-control study design was employed.
  • 163 hypertensive patients and 227 healthy participants were recruited.
  • All participants underwent coronary angiography to assess for CAS.

Main Results:

  • Coronary artery stenosis (CAS), BMI, and age were significantly associated with hypertension.
  • Stratified analysis revealed that BMI and age were the sole significant predictors of hypertension in participants without CAS.
  • Abdominal obesity did not remain a significant predictor in the final model, irrespective of stenosis presence.

Conclusions:

  • BMI and age are the most potent predictors of hypertension in individuals without coronary artery stenosis.
  • Coronary artery stenosis significantly modifies the association between common risk factors and the presence of hypertension.
  • Understanding these interactions is crucial for managing hypertension and preventing cardiovascular diseases.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
621
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422